Development and Validation of a New Adherence Scale for Antiseizure Medications [ASASM].

The objective was to develop and validate a multidimensional scale that measures adherence levels to antiseizure medications and detects patients' reasons for non-adherence. A new scale was developed, namely the "Adherence Scale for Anti-Seizure Medication(s)-10 items [ASASM-10]". It consists of ten statements that cover different causes of non-adherence to antiseizure medications.

Non-Adherence to Antiseizure Medications: Rate and Predictors in Saudi Arabia.

: The objective of this paper is to determine the rate and predictors of non-adherence to antiseizure medications in Saudi Arabia. : A cross-sectional study which involved questionnaires and data collection from patients' medical records was conducted at neurology clinics. The rate of non-adherence to antiseizure medications was measured using "the Medication Adherence Rating Scale" (MARS).

Improving Venous Thromboembolism Prophylaxis Through Service Integration, Policy Enhancement, and Health Informatics.

Introduction: Venous thromboembolism (VTE) prevention and management are susceptible issues that require specific rules to sustain and oversee their functioning, as preventing VTE is a vital patient safety priority. This paper aims to investigate and provide recommendations for VTE assessment and reassessment through policy enhancement and development.

Methods: We reviewed different papers and policies to propose recommendations and theme analysis for policy modifications and enhancements to improve VTE prophylaxis and management.

Complementary and Alternative Medicine Practice Among Saudi Patients with Chronic Kidney Disease: A Cross-Sectional Study.

Objective: Complementary and alternative medicine (CAM) practice in patients with chronic kidney disease (CKD) has significantly increased. However, statistics regarding CAM practices among patients with CKD in Saudi and worldwide are limited. Hence, this study aimed to explore the prevalence and types of CAM in Saudi patients with CKD.